Close
Help
Need Help?



New Breast Cancer: Basic and Clinical Research Call for Papers

Posted Tue, Jun, 19,2012

The Editor in Chief, Dr Goberdhan P. Dimri, is pleased to announce a new call for papers for Breast Cancer: Basic and Clinical Research. Submissions are being accepted now.All authors who submit their manuscripts to Libertas will benefit from:Convenient 3-step online manuscript submissionNo space restrictions or color figure chargesOptional immediate publicationInclusion of your article in: Pubmed...

Continue Reading →

Posted in: Calls for Papers

Pubmed and Open Access Visibility in Biomarker Insights

Posted Tue, Jun, 19,2012

Articles published in open access journals like Biomarker Insights have been shown to receive more citations than articles published in restricted access journals.A recent review of the studies on open access citation advantage found that 87% of previous research showed open access articles to be more often cited than restricted access articles. An article’s citation level gives a good indic...

Continue Reading →

Breast Cancer: Basic and Clinical Research Joins COPE

Posted Tue, Jun, 19,2012

Breast Cancer: Basic and Clinical Research has formally joined the Committee on Publishing Ethics.COPE provides guidelines that are applied in situations such as where plagiarism allegations are made against a paper.  By becoming a COPE member there can be no doubt amongst authors of questionable papers that journals will apply commonly accepted industry-standard guidelines.  In more dif...

Continue Reading →

Latest Libertas Article Visibility Statistics

Posted Tue, Jun, 19,2012

The latest visibility statistics for the Libertas website are now available and article views have just exceeded 7.4 million. Article downloads since 2010 are just under 2.5 million and Libertas has over 70,000 registered users. The most viewed article has nearly 15,000 views, and the most cited article over 400 citations.Statistics from PubMed have also recently been updated, and article views th...

Continue Reading →

Immunology and Immunogenetics Insights Now on SCOPUS

Posted Mon, Jun, 18,2012

We’re pleased to announce that Immunology and Immunogenetics Insights is now indexed by SCOPUS and journal content will be available there soon.SCOPUS is the world’s largest collection of peer-reviewed literature and abstracts, with over 45.5 million records available online from 18,000 journals.Libertas understands the importance of indexing with SCOPUS and the inclusion of Immunology...

Continue Reading →

Infectious Diseases: Research and Treatment Email Alerts

Posted Mon, Jun, 18,2012

A key component of Libertas' high quality service to Infectious Diseases: Research and Treatment authors and readers is the free email alerts service, which keeps recipients updated on Infectious Diseases: Research and Treatment newly published articles and journal news.Email alerts recipients receive short, plain text notifications whenever a new article is published.  Notifications are ...

Continue Reading →

Posted in: Libertas Services

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
In my opinion the review process in all the Libertas Academica journals I have had the privilege of reviewing papers for is second to none.  The entire process is a click away and all the editorial staff are very cooperative.  The papers that are submitted are of top quality and I am sure the journals will gain the status of high impact journals in a very short time.
Dr C. Shekhar Mayanil (Children's Memorial Research Center, Chicago, IL, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results